tiprankstipranks
Advertisement
Advertisement

DNTH Stock Latest News

Dianthus price target raised to $128 from $110 at Truist
The FlyDianthus price target raised to $128 from $110 at Truist
8m ago
DNTH
Dianthus price target raised to $158 from $130 at H.C. Wainwright
PremiumThe Fly
Dianthus price target raised to $158 from $130 at H.C. Wainwright
2h ago
DNTH
Dianthus price target raised to $122 from $105 at Wedbush
PremiumThe Fly
Dianthus price target raised to $122 from $105 at Wedbush
22h ago
DNTH
Dianthus Maintained at Buy as Strong Cash Runway and DNTH312 Pipeline Potential Support Unchanged $125 Price Target
PremiumRatings
Dianthus Maintained at Buy as Strong Cash Runway and DNTH312 Pipeline Potential Support Unchanged $125 Price Target
2d ago
DNTH
Dianthus reports Q2 EPS (90c), consensus (91c)
PremiumThe Fly
Dianthus reports Q2 EPS (90c), consensus (91c)
2d ago
DNTH
Dianthus Advances Claseprubart Into Phase 3 EMERGE Trial, Raising Stakes in the Myasthenia Gravis Market
PremiumCompany AnnouncementsDianthus Advances Claseprubart Into Phase 3 EMERGE Trial, Raising Stakes in the Myasthenia Gravis Market
29d ago
DNTH
Dianthus initiates EMERGE trial of claseprubart
Premium
The Fly
Dianthus initiates EMERGE trial of claseprubart
1M ago
DNTH
Dianthus’ new CAPTIVATE responder rate beat expectations, says Raymond James
Premium
The Fly
Dianthus’ new CAPTIVATE responder rate beat expectations, says Raymond James
2M ago
SNY
DNTH
Dianthus reports additional data from Part A of CAPTIVITY study
PremiumThe Fly
Dianthus reports additional data from Part A of CAPTIVITY study
2M ago
DNTH
Dianthus rises 7.7%
PremiumThe Fly
Dianthus rises 7.7%
2M ago
DNTH
Dianthus Highlights Positive CAPTIVATE Phase 3 Interim Results
PremiumCompany Announcements
Dianthus Highlights Positive CAPTIVATE Phase 3 Interim Results
2M ago
8K
DNTH
Dianthus price target raised to $132 from $110 at Jefferies
PremiumThe Fly
Dianthus price target raised to $132 from $110 at Jefferies
2M ago
SNY
DNTH
Midday Fly By: SpaceX IPO oversubscribed, Chewy reports in-line Q1
PremiumThe FlyMidday Fly By: SpaceX IPO oversubscribed, Chewy reports in-line Q1
2M ago
F
SN
Dianthus falls -16.0%
Premium
The Fly
Dianthus falls -16.0%
2M ago
DNTH
Analyst Maintains Buy Rating on Claseprubart Developer, Keeps $125 Price Target Unchanged Amid Confidence in Trial Design and Potency
Premium
Ratings
Analyst Maintains Buy Rating on Claseprubart Developer, Keeps $125 Price Target Unchanged Amid Confidence in Trial Design and Potency
2M ago
DNTH
Dianthus falls -13.7%
PremiumThe Fly
Dianthus falls -13.7%
2M ago
DNTH
Analyst Reiterates Buy on Dianthus Therapeutics, Keeping $130 Price Target Amid Confidence in Claseprubart’s Best-in-Class Potential
PremiumRatings
Analyst Reiterates Buy on Dianthus Therapeutics, Keeping $130 Price Target Amid Confidence in Claseprubart’s Best-in-Class Potential
2M ago
DNTH
Buy Dianthus on weakness amid ‘overdone’ selloff, says H.C. Wainwright
PremiumThe Fly
Buy Dianthus on weakness amid ‘overdone’ selloff, says H.C. Wainwright
2M ago
SNY
DNTH
Video: Cracker Barrel advances after beat and raise report
PremiumThe Fly
Video: Cracker Barrel advances after beat and raise report
2M ago
SNY
CBRL
Morning Movers: Dianthus plummets after peer Sanofi halts trial
PremiumThe FlyMorning Movers: Dianthus plummets after peer Sanofi halts trial
2M ago
YB
CNM
Stifel says Sanofi stopping MOBILIZE study potentially positive for Dianthus
Premium
The Fly
Stifel says Sanofi stopping MOBILIZE study potentially positive for Dianthus
2M ago
SNY
DNTH
Dianthus sinks after Sanofi halts CIDP Phase 3 study
Premium
The Fly
Dianthus sinks after Sanofi halts CIDP Phase 3 study
2M ago
SNY
DNTH

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >